These drivers activate signaling pathways such as MAPK, PI3K/Akt/mTOR, STAT, and NF‐kB to induce cellular proliferation, anti‐apoptosis, metabolic reprogramming, EMT, tumor‐promoting inflammation, immune destruction, angiogenesis, and tumor invasion [75]. Here, NFKB1 is linked to neoplasm.